Buckingham Strategic Wealth, LLC Biogen Inc. Transaction History

Buckingham Strategic Wealth, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 30, 2021	SELL	$242.95 - $284.63 $281,579 - $329,886	-1,159 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $273,825 - $412,175	1,159 New	1,159 $284,000
Q2 2020 Aug 03, 2020	SELL	$258.66 - $342.55 $226,327 - $299,731	-875 Closed	0 $0
Q1 2020 May 07, 2020	BUY	$268.85 - $341.04 $8,872 - $11,254	33 Added 3.92%	875 $277,000
Q4 2019 Feb 04, 2020	BUY	$220.06 - $304.07 $185,290 - $256,026	842 New	842 $250,000
Q3 2019 Nov 12, 2019	SELL	$217.44 - $243.88 $278,105 - $311,922	-1,279 Closed	0 $0
Q2 2019 Aug 05, 2019	SELL	$219.29 - $241.72 $85,303 - $94,029	-389 Reduced 23.32%	1,279 $299,000
Q1 2019 May 02, 2019	BUY	$216.71 - $338.96 $186,370 - $291,505	860 Added 106.44%	1,668 $394,000
Q4 2018 Feb 11, 2019	SELL	$278.5 - $352.75 $10,583 - $13,404	-38 Reduced 4.49%	808 $243,000
Q3 2018 Nov 02, 2018	BUY	$293.51 - $383.83 $11,740 - $15,353	40 Added 4.96%	846 $299,000
Q2 2018 Aug 13, 2018	BUY	$257.52 - $306.91 $207,561 - $247,369	806 New	806 $234,000
Q1 2018 May 14, 2018	SELL	$260.13 - $367.91 $170,905 - $241,716	-657 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$307.64 - $344.58 $202,119 - $226,389	657	657 $209,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Buckingham Strategic Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Buckingham Strategic Wealth, LLC with notifications on news.